19-38499306-G-A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000540.3(RYR1):c.7027+63G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00518 in 1,611,672 control chromosomes in the GnomAD database, including 231 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as not provided (no stars).
Frequency
 Genomes: 𝑓 0.0075   (  31   hom.,  cov: 32) 
 Exomes 𝑓:  0.0049   (  200   hom.  ) 
Consequence
 RYR1
NM_000540.3 intron
NM_000540.3 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -1.86  
Publications
2 publications found 
Genes affected
 RYR1  (HGNC:10483):  (ryanodine receptor 1) This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008] 
RYR1 Gene-Disease associations (from GenCC):
- malignant hyperthermia, susceptibility to, 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp, Ambry Genetics
- congenital multicore myopathy with external ophthalmoplegiaInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
- RYR1-related myopathyInheritance: AR, AD Classification: DEFINITIVE Submitted by: ClinGen
- central core myopathyInheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
- King-Denborough syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- malignant hyperthermia of anesthesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive centronuclear myopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- benign Samaritan congenital myopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- congenital myopathy with myasthenic-like onsetInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- lethal multiple pterygium syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9). 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.063  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.00754  AC: 1148AN: 152192Hom.:  31  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
1148
AN: 
152192
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.00493  AC: 7195AN: 1459362Hom.:  200   AF XY:  0.00522  AC XY: 3787AN XY: 726108 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
7195
AN: 
1459362
Hom.: 
 AF XY: 
AC XY: 
3787
AN XY: 
726108
show subpopulations 
African (AFR) 
 AF: 
AC: 
18
AN: 
33438
American (AMR) 
 AF: 
AC: 
1828
AN: 
44710
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
48
AN: 
26126
East Asian (EAS) 
 AF: 
AC: 
2891
AN: 
39682
South Asian (SAS) 
 AF: 
AC: 
1753
AN: 
86146
European-Finnish (FIN) 
 AF: 
AC: 
19
AN: 
53006
Middle Eastern (MID) 
 AF: 
AC: 
9
AN: 
5758
European-Non Finnish (NFE) 
 AF: 
AC: 
196
AN: 
1110176
Other (OTH) 
 AF: 
AC: 
433
AN: 
60320
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.468 
Heterozygous variant carriers
 0 
 420 
 840 
 1259 
 1679 
 2099 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 100 
 200 
 300 
 400 
 500 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.00754  AC: 1148AN: 152310Hom.:  31  Cov.: 32 AF XY:  0.00924  AC XY: 688AN XY: 74466 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
1148
AN: 
152310
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
688
AN XY: 
74466
show subpopulations 
African (AFR) 
 AF: 
AC: 
58
AN: 
41586
American (AMR) 
 AF: 
AC: 
558
AN: 
15294
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
4
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
357
AN: 
5184
South Asian (SAS) 
 AF: 
AC: 
127
AN: 
4826
European-Finnish (FIN) 
 AF: 
AC: 
1
AN: 
10624
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
18
AN: 
68006
Other (OTH) 
 AF: 
AC: 
25
AN: 
2112
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 58 
 115 
 173 
 230 
 288 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 20 
 40 
 60 
 80 
 100 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
188
AN: 
3478
ClinVar
Significance: not provided 
Submissions summary: Other:1 
Revision: no classification provided
LINK: link 
Submissions by phenotype
not provided    Other:1 
-
RYR1 database
Significance:not provided
Review Status:no classification provided
Collection Method:literature only
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.